Efficacy and safety of hemodilutional autologous blood transfusion for intermediate- to advanced- liver resection : An observational study

Phase 1

Recruiting

• Conditions: All disease which would be required for hepatectomy; hepatectomy, hemodilutionalautologous blood transfusion (HAT)

• Registration Number: JPRN-jRCT1050220063
• Lead Sponsor: chida Yoichiro

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-07-14
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

1. More than 18 years
2. All disease which would be required for hepatectomy
3. intermediate-to-difficult hepatectomy
4. HAT cases

Exclusion Criteria

1. Hepatectomy with concomitant some surgery (e.g., gastrectomy or pancreaticoduodenecrtomy)
2. Donor hepatectomy

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Intraoperative allogeneic blood transfusion

Secondary Outcome Measures

Name	Time	Method
Intraoperative setting: bleedings(before and after HAT), amont of loss of Hb, coagulation test<br>Postoperative setting: Complications according to the Clavien-Dindo classification, allogeneic blood transfusion (amount or rate), posthepatectomy liver failure (PHLF)